Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ejegod · SciRah

Researcher profile · Semantic Scholar

D. Ejegod

Share profile

D. Ejegod — researcher profile on SciRah

h-index: 21
Works: 47
Citations: 1,070

Most-cited papers

Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
J. Bonde, A. Floore, D. Ejegod, F. Vink +20 more
2020International Journal of Cancer120 citations Open access
Semantic Scholar
Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
M. Rebolj, S. Preisler, D. Ejegod, C. Rygaard +2 more
2014PLoS ONE76 citations Open access
Semantic Scholar
Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
S. Preisler, M. Rebolj, Anette Untermann, D. Ejegod +3 more
2013PLoS ONE53 citations Open access
Semantic Scholar
Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review
J. Bonde, F. Bottari, A. D. Iacobone, C. Cocuzza +6 more
2020Journal of Lower Genital Tract Disease51 citations Open access
Semantic Scholar
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
J. Bonde, M. Rebolj, D. Ejegod, S. Preisler +2 more
2014BMC Infectious Diseases46 citations Open access
Semantic Scholar
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
M. Rebolj, J. Bonde, S. Preisler, D. Ejegod +2 more
2016PLoS ONE44 citations Open access
Semantic Scholar
The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium.
J. Bonde, D. Ejegod, K. Cuschieri, J. Dillner +7 more
2018Journal of Clinical Virology42 citations Open access
Semantic Scholar
Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
D. Ejegod, H. Pedersen, G. P. Alzua, Camilla Pedersen +1 more
2018Papillomavirus Research41 citations Open access
Semantic Scholar
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
D. Ejegod, F. Bottari, H. Pedersen, M. Sandri +1 more
2016Journal of Clinical Microbiology38 citations Open access
Semantic Scholar
Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
D. Ejegod, J. Junge, M. Franzmann, B. Kirschner +4 more
2016Papillomavirus Research37 citations Open access
Semantic Scholar
Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark.
B. Goldman, M. Rebolj, C. Rygaard, S. Preisler +3 more
2013Vaccine35 citations
Semantic Scholar
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
J. Bonde, F. Bottari, V. Parvu, H. Pedersen +7 more
2019International Journal of Cancer34 citations Open access
Semantic Scholar
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
J. Bonde, H. Pedersen, W. Quint, Lan Xu +2 more
2019Journal of Clinical Microbiology32 citations Open access
Semantic Scholar
Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology.
M. Rebolj, E. Lynge, D. Ejegod, S. Preisler +2 more
2014Gynecologic Oncology32 citations Open access
Semantic Scholar
High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
J. Lam, K. M. Elfström, D. Ejegod, H. Pedersen +7 more
2017British Journal of Cancer31 citations Open access
Semantic Scholar
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
S. Preisler, M. Rebolj, D. Ejegod, E. Lynge +2 more
2016BMC Cancer31 citations Open access
Semantic Scholar
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
M. Rebolj, J. Bonde, S. Preisler, D. Ejegod +2 more
2016Journal of Clinical Microbiology28 citations Open access
Semantic Scholar
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years.
M. Rebolj, J. Bonde, D. Ejegod, S. Preisler +2 more
2015European Journal of Cancer27 citations Open access
Semantic Scholar
Clinical Validation of the BD Onclarity™ HPV Assay Using a Non-Inferiority Test
D. Ejegod, J. Bonde, I. Serrano, K. Cuschieri +4 more
201527 citations Open access
Semantic Scholar
Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
D. Ejegod, H. Pedersen, B. T. Pedersen, R. Serizawa +1 more
2022Preventive Medicine25 citations Open access
Semantic Scholar
Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay.
M. Rebolj, S. Preisler, D. Ejegod, J. Bonde +2 more
2013Journal of Molecular Diagnostics22 citations Open access
Semantic Scholar
The challenges of defining sample adequacy in an era of HPV based cervical screening.
K. Cuschieri, A. Wilson, T. Palmer, G. Stanczuk +3 more
2021Journal of Clinical Virology21 citations
Semantic Scholar
Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions
F. Bottari, M. Sideri, C. Gulmini, S. Igidbashian +7 more
2015Journal of Clinical Microbiology21 citations Open access
Semantic Scholar
Results from the SARS-CoV-2 wastewater-based surveillance system in Denmark, July 2021 to June 2022.
L. Krogsgaard, Guido Benedetti, Aina Gudde, S. R. Richter +19 more
2024Water Research18 citations Open access
Semantic Scholar
Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders
J. Lam, M. Rebolj, D. Ejegod, H. Pedersen +6 more
2017Journal of Clinical Microbiology18 citations Open access
Semantic Scholar
Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.
D. Ejegod, Mona Hansen, I. K. Christiansen, H. Pedersen +4 more
2020Journal of Clinical Virology16 citations
Semantic Scholar
Participation and relative cost of attendance by direct‐mail compared to opt‐in invitation strategy for HPV self‐sampling targeting cervical screening non‐attenders: A large‐scale, randomized, pragmatic study
B. T. Pedersen, S. B. Sonne, H. Pedersen, Emilie Korsgaard Andreasen +3 more
2024International Journal of Cancer15 citations Open access
Semantic Scholar
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
D. Ejegod, M. Rebolj, J. Bonde
2015BMC Cancer15 citations Open access
Semantic Scholar
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
D. Ejegod, C. Lagheden, R. Bhatia, H. Pedersen +7 more
2020BMC Cancer14 citations Open access
Semantic Scholar
Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
D. Heideman, Lan Xu, A. Hesselink, S. Doorn +5 more
2019Journal of Clinical Virology10 citations Open access
Semantic Scholar
Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening
M. Rebolj, S. Njor, Elsebeth Lynge, S. Preisler +3 more
2017Cytopathology10 citations Open access
Semantic Scholar
Control of Pathogenicity and Disease Specificity of a T-Lymphomagenic Gammaretrovirus by E-Box Motifs but Not by an Overlapping Glucocorticoid Response Element
D. Ejegod, K. D. Sørensen, I. Mossbrugger, L. Quintanilla-Martinez +2 more
2008Journal of Virology8 citations Open access
Semantic Scholar
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
D. Ejegod, H. Pedersen, B. T. Pedersen, C. Jonassen +4 more
2021American Journal of Clinical Pathology7 citations Open access
Semantic Scholar
Evaluation of HarmoniaHPV test for detection of clinically significant Human Papillomavirus infection using the VALGENT framework.
R. Bhatia, Elia Alcañiz Boada, J. Bonde, W. Quint +6 more
2021Journal of Virological Methods6 citations
Semantic Scholar
Clinical validation of point-of-care SARS-COV-2 BD Veritor antigen test by a single throat swab for rapid COVID-19 status on hospital patients predominantly without overt COVID symptoms
J. Bonde, D. Ejegod, H. Pedersen, Birgitte Smith +9 more
2021medRxiv5 citations Open access
Semantic Scholar
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
R. Bhatia, Elia Alcañiz Boada, J. Bonde, W. Quint +4 more
2021Journal of Clinical Pathology4 citations Open access
Semantic Scholar
Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes☆
Magdalena Dabrowska, D. Ejegod, L. B. Lassen, H. Johnsen +3 more
2013Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis3 citations Open access
Semantic Scholar
Construction of a Gammaretrovirus with a Novel Tropism and Wild-Type Replication Kinetics Capable of Using Human APJ as Entry Receptor
S. Bahrami, K. Pagh, D. Ejegod, M. Duch +2 more
2012Journal of Virology3 citations Open access
Semantic Scholar
Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework.
D. Ejegod, H. Pedersen, W. Quint, Lan Xu +2 more
2021Journal of Virological Methods2 citations Open access
Semantic Scholar
Coupling of receptor interference and a host-dependent post-binding entry deficiency in a gammaretroviral envelope protein
S. Bahrami, D. Ejegod, K. D. Sørensen, F. Pedersen
2010Retrovirology2 citations Open access
Semantic Scholar
Clinical performance of the full genotyping Agena MassARRAY HPV assay using SurePath screening samples within the VALGENT4 framework.
H. Pedersen, D. Ejegod, W. Quint, Lan Xu +2 more
2022Journal of Molecular Diagnostics1 citations Open access
Semantic Scholar
HPV Screening in the way to cervical cancer elimination
T. Iftner, Sara Smith, Philip E. Castle, J. Bonde +21 more
20181 citations
Semantic Scholar
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
S. Preisler, M. Rebolj, D. Ejegod, E. Lynge +2 more
2016BMC Cancer1 citations Open access
Semantic Scholar
Eurofins Covid-19 Sentinel™ Wastewater Test Provides Early Warning of COVID-19
A. Jørgensen, J. Gamst, L. Hansen, I. Rasmussen +3 more
2023Medical Research Archives0 citations Open access
Semantic Scholar
Clinical validation of the Liferiver Harmonia HPV assay using the VALGENT-4 framework
R. Bhatia, K. Cuschieri, D. Ejegod, J. Bonde +1 more
20180 citations
Semantic Scholar
' s response to reviews Title : Comparison of CLART HPV 2 genotyping assay to Linear Array and Hybrid Capture 2 : a split-sample study
D. Ejegod, M. Rebolj, J. Bonde
20150 citations
Semantic Scholar
Gene Expression Profiling of Murine T-Cell Lymphoblastic Lymphoma Identifies Deregulation of S-Phase Initiating Genes.
K. Dybkær, Magdalena Dabrowska, D. Ejegod, L. B. Lassen +3 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Bonde×33
Invite
J. Bonde — researcher profile on SciRah
H. Pedersen×16
Invite
H. Pedersen — researcher profile on SciRah
M. Rebolj×16
Invite
M. Rebolj — researcher profile on SciRah
C. Rygaard×14
Invite
C. Rygaard — researcher profile on SciRah

×12

Invite

S. Preisler — researcher profile on SciRah

Invite

E. Lynge — researcher profile on SciRah

K. Cuschieri×9

Invite

K. Cuschieri — researcher profile on SciRah

Invite

M. Arbyn — researcher profile on SciRah

Invite

W. Quint — researcher profile on SciRah

Invite

R. Bhatia — researcher profile on SciRah

Invite

J. Bonde — researcher profile on SciRah

Invite

F. Bottari — researcher profile on SciRah